Live Breaking News & Updates on Atriva Therapeutics

Stay updated with breaking news from Atriva therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology

Atriva Therapeutics and Canadian Biocure Technologies, Inc. entered into an exclusive letter agreement for a reverse takeover transaction. Upon successful completion of the transaction, the resulting entity will continue the business of Atriva Therapeutics. Shareholders of Atriva will receive not less than 75% of the securities of the resulting issuer, with the current shareholders of Biocure Technology holding the remainder. The transaction is subject to various terms and conditions, including ....

South Korea , British Columbia , Christian Pangratz , Ulrich Dauer , Biocure Technology , Canadian Biocure Technologies Inc , Biocure Technology Inc , Atriva Therapeutics , Canadian Biocure Technologies , Therapeutics Gmbh , Chief Executive Officer , Advisory Board , Interferon Beta , Letter Agreement , Successful Completion , Iocure Technology Inc , Private Placement , Pandemic Preparedness , Christian Pangratz ,

Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer

EQS-News: Adrenomed AG / Key word(s): PersonnelAdrenomed appoints Dr. Stephan Witte as Chief Medical Officer 01.02.2023 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Press Release Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer Hennigsdorf/Berlin (Germany),. ....

Baden Wüberg , Richard Jones , Helion Pharma , Stephan Witte , Eva Bauer Julia , Mc Services , European Center , Distribution Services , Head Of Clinical Development , Regulatory Affairs At Inotrem , University Of Konstanz , Chief Medical Officer , Vice President Clinical Science , Atriva Therapeutics , Vice President Clinical Trials , Breath Therapeutics , Clinical Development , Regulatory Affairs , Advanced Studies , Pharmaceutical Medicine , Corporate News , Regulatory Announcements ,